Clinical Trial Update: Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing safety and tolerability of crofelemer for HIV-associated diarrhea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Enteropathy
• Hiv-associated Diarrhea

Drugs mentioned

• Crofelemer (crofelemer)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: HIV Enteropathy, Diarrhea With HIV | Phase 3 | Status: COMPLETED | Results posted: 2020-08-17